Bruker Corporation announced that it has acquired JPK Instruments AG (JPK), located in Berlin, Germany. In 2017, JPK Instruments had revenue of approximately 10 million Euro. JPK provides...
Thermo Fisher Scientific Inc., the world leader in serving science, announced that its Board of Directors has declared a quarterly cash dividend of USD 0.17 per common share,...
Johnson & Johnson issued the following statement regarding today’s verdict in the St. Louis court. “Johnson & Johnson is deeply disappointed in the verdict, which was the product...
Luminex Corporation announced that it expects to report results for the second quarter ended June 30, 2018 on Monday, August 6, 2018. A press release announcing the results is...
Roche announced that it has received clearance from the US Food and Drug Administration (FDA) for the expanded use of its Elecsys B·R·A·H·M·S PCT assay to...
Amgen and UCB (Euronext Brussels: UCB) announced the resubmission of the Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for EVENITY (romosozumab),...
The US Food and Drug Administration is alerting healthcare professionals and patients of a voluntary recall of several drug products containing the active ingredient valsartan, used...
Astellas Pharma Inc. and Pfizer Inc. announced the US Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) for XTANDI (enzalutamide), following FDA Priority...
Medtronic plc has received United States Food and Drug Administration (FDA) approval for a less-invasive implant approach of its HVAD System, a left ventricular assist device...
Qiagen N.V. announced a partnership with multiple organizations to support creating a global genomics campus in Manchester, UK, for innovation, life sciences, translational science and molecular...
Bristol-Myers Squibb Company announced Opdivo (nivolumab) 3 mg/kg plus low-dose Yervoy (ipilimumab) 1 mg/kg (injections for intravenous use) received approval from the US Food and Drug...
Pfizer Inc. announced it will organize the company into three businesses: a science-based Innovative Medicines business which will now include biosimilars and a new hospital business...
BD (Becton, Dickinson and Company), a leading global medical technology company, issued its 2017 Sustainability Performance Update that focuses on four key strategic areas that support...
AbbVie, a research-based global biopharmaceutical company, announced it submitted a supplemental New Drug Application (sNDA) to the US Food and Drug Administration (FDA) for venetoclax in...
Quest Diagnostics Incorporated, the world’s leading provider of diagnostic information services, announced that it will report second quarter 2018 results on Tuesday, July 24, 2018, before the...
Copyright © 2024 Medical Buyer